Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group

J Infect Dis. 1995 Jun;171(6):1675-8. doi: 10.1093/infdis/171.6.1675.

Abstract

The levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1 beta in the cerebrospinal fluid (CSF) of 66 patients with coccidioidal meningitis during therapy with fluconazole were measured by ELISA. The median concentration of TNF-alpha was 15.2 pg/mL for 322 samples; for IL-1 beta, it was 4.7 pg/mL for 316 samples. There were no significant changes in the level of either cytokine over 24 months of follow-up nor was there an association between the initial CSF concentrations of TNF-alpha and IL-1 beta and subsequent fluconazole treatment failure. Over time, concentrations of IL-1 beta were significantly associated with both clinical symptoms and white blood cell counts in CSF. These results indicate that CSF levels of TNF-alpha and IL-1 beta are relatively low compared with those associated with acute bacterial meningitis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coccidioidomycosis / cerebrospinal fluid*
  • Fluconazole / therapeutic use*
  • Humans
  • Interleukin-1 / cerebrospinal fluid*
  • Meningitis, Fungal / cerebrospinal fluid*
  • Meningitis, Fungal / drug therapy*
  • Time Factors
  • Tumor Necrosis Factor-alpha / cerebrospinal fluid*

Substances

  • Interleukin-1
  • Tumor Necrosis Factor-alpha
  • Fluconazole